Tender detail
Non-exclusive pharmaceutical discount agreements for perindopril/amlodipine/indapamide
Summary
The procurement concerns non-exclusive pharmaceutical discount agreements under an open-house model for medicines containing perindopril, amlodipine and indapamide, limited to the strength 7 mg/5 mg/2.5 mg. Demand and purchase volumes are unknown, and no minimum quantities are guaranteed. The agreements end no later than 31 July 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.